Bionano Genomics (BNGO) Cash from Operations (2017 - 2026)
Bionano Genomics (BNGO) posted Cash from Operations of 5700000.0 for Q1 2026, down 38.01% sequentially from 4130000.0 in Q4 2025, and down 106.22% YoY from 91597674.42 in Q1 2025.
Bionano Genomics (BNGO) Cash from Operations (2017 - 2026) Analysis & Trends
Bionano Genomics has reported Cash from Operations for 10 years, with the latest figure at 5700000.0 in Q1 2026.
- Quarterly Cash from Operations fell 106.22% year-over-year to 5700000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 19236000.0 (up 55.84% YoY) and the FY2025 annual result came in at 16300000.0, up 76.35% from the prior year.
- Cash from Operations eased to 5700000.0 in Q1 2026 per BNGO's latest filing, from 4130000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 2764000.0 in Q1 2025 and troughed at 36696000.0 in Q2 2023.
- A 5-year average of 20054058.82 and a median of 26293000.0 in 2023 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2022 and 2025: Cash from Operations plunged 133.7% in 2022, then soared 90.17% in 2025.
- Over 5 years, Cash from Operations stood at 34517000.0 in 2022, then climbed by 13.73% to 29779000.0 in 2023, then surged by 78.16% to 6504000.0 in 2024, then surged by 36.5% to 4130000.0 in 2025, then plunged by 38.01% to 5700000.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 5700000.0, 4130000.0, and 5919000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 1.06 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 776.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 510.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 454.63 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 715.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 124.00 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 227.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 182.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 297.00 Mn |
| 10 | Bionano Genomics | 13.74 Mn | 3.81 Mn | 4.31 Mn | -4.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.68 Mn |
| Jun 30, 2026 | -4.68 Mn |
| Mar 31, 2026 | -5.70 Mn |
| Mar 31, 2026 | -5.70 Mn |
| Dec 31, 2025 | -4.13 Mn |
| Dec 31, 2025 | -4.13 Mn |
| Sep 30, 2025 | -5.92 Mn |
| Sep 30, 2025 | -5.92 Mn |
| Jun 30, 2025 | -3.49 Mn |
| Jun 30, 2025 | -3.49 Mn |
| Mar 31, 2025 | -2.76 Mn |
| Mar 31, 2025 | -2.76 Mn |
| Dec 31, 2024 | -6.50 Mn |
| Dec 31, 2024 | -6.50 Mn |
| Sep 30, 2024 | -13.31 Mn |
| Sep 30, 2024 | -13.31 Mn |
| Jun 30, 2024 | -20.98 Mn |
| Jun 30, 2024 | -20.98 Mn |
| Mar 31, 2024 | -28.13 Mn |
| Mar 31, 2024 | -28.13 Mn |